Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Takeaway: The overwhelming majority of patients taking Ozempic or Wegovy will not experience this type of optic nerve damage
Novo Nordisk, Hims & Hers settle GLP-1 drug dispute Kimberly Redmond 9, 2026// The basics: Novo Nordisk, Hims & Hers resolve GLP-1 drug lawsuit Wegovy, Ozempic to be offered on Hims & Hers platform Hims & Hers agrees to stop selling compounded semaglutide FDA-backed deal expands access to approved weight-loss drugs Novo Nordisk and Hims & Hers have ended a legal feud with an agreement that allows the telehealth platform to sell the pharma giants blockbuster brand-name GLP-1 drugs
It activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
The probe is expected to end in November
PMID: 32932644
US$ 28.00
US$ 21.77
US$ 23.84
